A new genetic study offers glimpses into how scientists might use gene-sequencing data to customize pediatric patients’ cancer treatments.
Category Archive: Center for Childhood Cancer Research
Permanent link to this article: http://www.research.chop.edu/blog/genetic-study-suggests-fine-tuning-drugs-for-pediatric-brain-tumors/
Apr 10 2013
CHOP Leads ‘Dream Team’ as Stand Up to Cancer and St. Baldrick’s Take Aim at Children’s Cancers
A physician-researcher from The Children’s Hospital of Philadelphia will lead the first-ever pediatric “Dream Team” solely focused on creating new treatments for the most challenging childhood cancers.
Permanent link to this article: http://www.research.chop.edu/blog/chop-leads-dream-team-as-stand-up-to-cancer-and-st-baldricks-take-aim-at-childrens-cancers/
Mar 26 2013
Advanced Cell Therapy Eliminates Aggressive Leukemia in Two Children
According to new research from The Children’s Hospital of Philadelphia and the University of Pennsylvania, two children with an aggressive form of childhood leukemia achieved a complete response after being treated with an innovative cell therapy.
Permanent link to this article: http://www.research.chop.edu/blog/advanced-cell-therapy-eliminates-aggressive-leukemia-in-two-children/
Mar 07 2013
CHOP Researcher’s Innovative Immune Therapy Featured on The Doctors
The innovative work being done by CHOP’s Stephen Grupp, MD, was recently featured on the CBS show The Doctors. Dr. Grupp, the Center for Childhood Cancer Research’s director of translational research, discussed his trial using immune therapy to treat an aggressive form of childhood leukemia, acute lymphoblastic leukemia (ALL). While roughly 85 percent of ALL …
Permanent link to this article: http://www.research.chop.edu/blog/chop-researchers-innovative-immune-therapy-featured-on-the-doctors/
Jan 24 2013
Study Shows Neuroblastoma Evolves Rapidly, Limiting Treatment Targets
A recent genomic study of neuroblastoma reinforces the challenges of treating the most aggressive forms of this disease. Contrary to expectations, the researchers found relatively few recurrent gene mutations — mutations that would suggest new targets for neuroblastoma treatment. Instead, the investigators have refocused on how neuroblastoma tumors evolve in response to medicine and other factors.
Permanent link to this article: http://www.research.chop.edu/blog/study-shows-neuroblastoma-evolves-rapidly-limiting-treatment-targets/
Subscribe to Cornerstone
Loading tweets...
Recent Comments